First human tests for new drug in china focus on safety
NCT ID NCT06961708
Summary
This was an early-stage study to understand how the experimental drug fosmanogepix is processed by the body and to check its safety in healthy Chinese adults. The study involved 54 healthy volunteers who received either the drug or a placebo as a single dose or multiple doses, given by mouth or through an IV. The main goal was to measure drug levels in the blood and monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Xuhui Central Hospital, Longchuan North Road
Shanghai, 200237, China
Conditions
Explore the condition pages connected to this study.